Drugs / N-Acetylecysteine
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 1/2 | NCT03634566 Comparator | Apr 2018 → Feb 2019 | — | Ain Shams University | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | N-Acetylecysteine | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03634566 ↗ |
| Known as | NAC | “N-Acetylecysteine 150 mg/kg diluted in 100 ml glucose 5 % over 40 minutes followed by NAC 12.5 mg/kg in 500 ml glucose 5% over 4 hours, followed by NAC 6.25 mg/kg for 2...” NCT03634566 ↗ |